195 related articles for article (PubMed ID: 35936732)
1. Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis.
Liu X; Jiang T; Gao C; Liu H; Sun Y; Zou Q; Tang R; Zeng W
Front Oncol; 2022; 12():911146. PubMed ID: 35936732
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of
Liu X; Wang Q; Zhang B; Jiang T; Zeng W
Hell J Nucl Med; 2022; 25(1):88-102. PubMed ID: 35388806
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. The performance of
Qin ZQ; Pan GJ; Xu Z; Wang H; Xu LW; Jia RP
Asian J Androl; 2022; 24(4):373-379. PubMed ID: 34747721
[TBL] [Abstract][Full Text] [Related]
5. Detection Rate of
Treglia G; Annunziata S; Pizzuto DA; Giovanella L; Prior JO; Ceriani L
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31126071
[No Abstract] [Full Text] [Related]
6.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
7. PSMA-targeted Radiotracers versus
Tan N; Oyoyo U; Bavadian N; Ferguson N; Mukkamala A; Calais J; Davenport MS
Radiology; 2020 Jul; 296(1):44-55. PubMed ID: 32396045
[TBL] [Abstract][Full Text] [Related]
8. The Diagnostic Role of
Wang R; Shen G; Huang M; Tian R
Front Oncol; 2021; 11():684629. PubMed ID: 34222008
[TBL] [Abstract][Full Text] [Related]
9.
Ferrari M; Treglia G
Contrast Media Mol Imaging; 2021; 2021():3502389. PubMed ID: 35002568
[TBL] [Abstract][Full Text] [Related]
10. Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of Biochemically Recurrent Prostate Cancer: A Systematic Review and Meta-Analysis.
Sun J; Lin Y; Wei X; Ouyang J; Huang Y; Ling Z
Front Oncol; 2021; 11():649171. PubMed ID: 33981607
[No Abstract] [Full Text] [Related]
11. Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis.
Pereira Mestre R; Treglia G; Ferrari M; Pascale M; Mazzara C; Azinwi NC; Llado' A; Stathis A; Giovanella L; Roggero E
Eur J Clin Invest; 2019 Mar; 49(3):e13063. PubMed ID: 30580449
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
13. Comparison of
Ling SW; de Jong AC; Schoots IG; Nasserinejad K; Busstra MB; van der Veldt AAM; Brabander T
Eur Urol Open Sci; 2021 Nov; 33():61-71. PubMed ID: 34632423
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity, Specificity, and Predictors of Positive
Perera M; Papa N; Christidis D; Wetherell D; Hofman MS; Murphy DG; Bolton D; Lawrentschuk N
Eur Urol; 2016 Dec; 70(6):926-937. PubMed ID: 27363387
[TBL] [Abstract][Full Text] [Related]
15. Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis.
Treglia G; Pereira Mestre R; Ferrari M; Bosetti DG; Pascale M; Oikonomou E; De Dosso S; Jermini F; Prior JO; Roggero E; Giovanella L
Am J Nucl Med Mol Imaging; 2019; 9(2):127-139. PubMed ID: 31139496
[TBL] [Abstract][Full Text] [Related]
16. The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.
Eissa A; Elsherbiny A; Coelho RF; Rassweiler J; Davis JW; Porpiglia F; Patel VR; Prandini N; Micali S; Sighinolfi MC; Puliatti S; Rocco B; Bianchi G
Minerva Urol Nefrol; 2018 Oct; 70(5):462-478. PubMed ID: 29664244
[TBL] [Abstract][Full Text] [Related]
17.
Ceci F; Castellucci P; Graziani T; Farolfi A; Fonti C; Lodi F; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):31-39. PubMed ID: 30350010
[TBL] [Abstract][Full Text] [Related]
18. Parameters predicting [
Ahmadi Bidakhvidi N; Laenen A; Jentjens S; Deroose CM; Van Laere K; De Wever L; Mai C; Berghen C; De Meerleer G; Haustermans K; Joniau S; Everaerts W; Goffin K
EJNMMI Res; 2021 Apr; 11(1):41. PubMed ID: 33929626
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of
Zhou X; Jiang X; Liu L; Wang X; Li C; Yao Y; Kou Y; Shen J; Shen T; Li Z; Yang S; Zhou S; Liao H; Luo Z; Wu X; Chen S; Cheng Z
Transl Oncol; 2022 Jan; 15(1):101292. PubMed ID: 34837847
[TBL] [Abstract][Full Text] [Related]
20. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
